0A50.LSE Co-Diagnostics, Inc.

Healthcare Medical Devices London Exchange
- USD
Market cap
-
P/E
0.3x
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is 0A50.LSE undervalued?

Graham number

The Graham number of Co-Diagnostics, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Co-Diagnostics, Inc. fundamental analysis

No fundamental analysis for Co-Diagnostics, Inc. yet.

Co-Diagnostics, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Co-Diagnostics, Inc.

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C,…

Full company profile